Vertex Pharmaceuticals Incorporated
Company Information

50 Northern Ave
Boston, MA, 02210 United States
(617) 341-6100

Vertex Pharmaceuticals Incorporated Rankings

S&P 500 (June 30, 2014)

Top 3 Competitors

Unlock access to over 100 million contacts! Starting at only $50 per user/month*

  • Up-to-the moment intelligence helps you set strategy, prepare for sales calls, and close business.
  • Easy-to-read reports on over 85 million companies and 900 industries build your understanding of the companies you work with.
  • Reports are written by real industry experts. Their summaries save you hours of research.

Unlock a Hoover's Basic Subscription.
To talk to a Business Information Consultant please call (866) 473-3932

*Prices reflect per user/per month cost based on an annual subscription for a minimum of 5 users.


Vertex Pharmaceuticals Incorporated Company Profile

Vertex Pharmaceuticals aims to cure patients with previously incurable diseases. The biotechnology company uses an integrated, multidisciplinary approach -- employing biophysics, computer-based modeling, and functional genomics -- to speed up the discovery and development of new drugs. Its first commercial product, Incivek (telaprevir) for hepatitis C virus (HCV), was launched in 2011, and a second drug for cystic fibrosis, Kalydeco, was launched in 2012. The company has other drugs in development, including additional treatments for HCV and cystic fibrosis, as well as epilepsy and rheumatoid arthritis.